Cheng-Hock Toh

Title: Cheng-Hock Toh: Innovator in Medical Diagnostics

Introduction

Cheng-Hock Toh is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of lipoprotein-acute phase protein complexes. His innovative approach has the potential to improve patient outcomes by predicting risks associated with system failure or mortality.

Latest Patents

Cheng-Hock Toh holds a patent for a method that involves diagnosing a patient's condition through a series of steps. This method includes adding one or more reagents to a test sample, which consists of part of a blood sample from the patient. The process leads to the formation of a complex that includes at least one acute phase protein and one human lipoprotein, while avoiding fiber polymerization. The formation of this complex is measured over time to derive a time-dependent measurement profile. By determining the slope or total change in this profile, healthcare professionals can diagnose the patient's condition. A greater formation of the complex correlates with an increased probability of death, highlighting the method's importance in clinical settings.

Career Highlights

Cheng-Hock Toh is currently associated with Biomerieux, Inc., where he continues to advance his research and innovations in medical diagnostics. His work is instrumental in developing methods that can lead to timely interventions for patients at risk.

Collaborations

Cheng-Hock Toh collaborates with esteemed colleagues such as Timothy J Fischer and Colin Downey. These partnerships enhance the research and development of diagnostic methods, contributing to the overall advancement of medical technology.

Conclusion

Cheng-Hock Toh's contributions to medical diagnostics through his innovative patent demonstrate his commitment to improving patient care. His work exemplifies the impact of scientific research on healthcare outcomes.